Risk stratification of patients with chest pain has traditionally focused on identifying obstructive coronary artery disease (CAD). Using this traditional approach, many symptomatic individuals are ...
Nirmatrelvir–ritonavir has been shown to reduce progression to severe illness from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in unvaccinated high-risk outpatients. The effectiveness ...
BA.3.2 spread internationally after first being identified in South Africa in November 2024, with detections rising from September 2025 and reports from at least 23 countries by 11 February 2026. U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results